WO2003082262A3 - Compositions of venlafaxine base - Google Patents
Compositions of venlafaxine base Download PDFInfo
- Publication number
- WO2003082262A3 WO2003082262A3 PCT/EP2003/003311 EP0303311W WO03082262A3 WO 2003082262 A3 WO2003082262 A3 WO 2003082262A3 EP 0303311 W EP0303311 W EP 0303311W WO 03082262 A3 WO03082262 A3 WO 03082262A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- venlafaxine
- compositions
- venlafaxine base
- base
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03745289A EP1487429A2 (en) | 2002-03-28 | 2003-03-27 | Compositions of venlafaxine base |
AU2003226748A AU2003226748A1 (en) | 2002-03-28 | 2003-03-27 | Compositions of venlafaxine base |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36773602P | 2002-03-28 | 2002-03-28 | |
US60/367,736 | 2002-03-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003082262A2 WO2003082262A2 (en) | 2003-10-09 |
WO2003082262A3 true WO2003082262A3 (en) | 2004-07-29 |
Family
ID=28675392
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/003320 WO2003082806A1 (en) | 2002-03-28 | 2003-03-27 | Venlafaxine base |
PCT/EP2003/003311 WO2003082262A2 (en) | 2002-03-28 | 2003-03-27 | Compositions of venlafaxine base |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/003320 WO2003082806A1 (en) | 2002-03-28 | 2003-03-27 | Venlafaxine base |
Country Status (5)
Country | Link |
---|---|
US (2) | US20030191347A1 (en) |
EP (1) | EP1487429A2 (en) |
AR (2) | AR039165A1 (en) |
AU (2) | AU2003226748A1 (en) |
WO (2) | WO2003082806A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060246132A1 (en) * | 2003-02-07 | 2006-11-02 | Fjalar Johannsson | Sustained release formulations of venlafaxine |
US20050048118A1 (en) * | 2003-07-25 | 2005-03-03 | Joan Cucala Escoi | Modified release venlafaxine hydrochloride tablets |
EP1523979A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release pharmaceutical dosage form |
US20050142203A1 (en) * | 2003-12-30 | 2005-06-30 | Grant Heinicke | Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same |
PL1711169T3 (en) * | 2004-02-04 | 2007-10-31 | Alembic Ltd | Extended release coated minitablets of venlafaxine hydrochloride |
ATE554752T1 (en) | 2004-02-06 | 2012-05-15 | Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust | USE OF AMINOSALICYLATES IN IRRITABLE BOWEL SYNDROME WITH DIARRHEA AS THE PREMIUM SYMPTOM |
EP1711167A1 (en) * | 2004-02-06 | 2006-10-18 | Wyeth | Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
WO2005112901A1 (en) * | 2004-05-21 | 2005-12-01 | Lupin Ltd. | Novel extended release composition of venlafaxine hydrochloride containing polyvinyl acetate |
US20080306029A1 (en) * | 2004-05-28 | 2008-12-11 | Salix Pharmaceuticals, Inc. | Prevention, Treatment, and Amelioration of Radiation Induced Enteritis |
CN1955159B (en) | 2005-06-17 | 2010-11-24 | 山东绿叶制药有限公司 | Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use |
EP1904040A2 (en) * | 2005-07-15 | 2008-04-02 | Wyeth | Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
NZ565974A (en) * | 2005-08-24 | 2012-07-27 | Salix Pharmaceuticals Ltd | Balsalazide formulations and manufacture and use thereof |
US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
CN102212014B (en) * | 2010-04-09 | 2013-12-25 | 江苏豪森医药集团有限公司 | Crystal form of O-demethyl-venlafaxine glutamate, preparation method and medicinal application thereof |
US20130034604A1 (en) * | 2010-05-14 | 2013-02-07 | Alembic Pharmaceuticals Limited | Extended release formulations of desvenlafaxine base |
JP2014500234A (en) | 2010-10-01 | 2014-01-09 | シャンドン リュイェ ファーマシューティカル カンパニー リミテッド | Polymorphs of 4- [2-dimethylamino-1- (1-hydroxycyclohexyl) ethyl] phenyl 4-methylbenzoate hydrochloride, methods of making them and their use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999022724A2 (en) * | 1997-11-05 | 1999-05-14 | American Home Products Corporation | Extended release formulation containing venlafaxin |
WO2000032555A1 (en) * | 1998-12-01 | 2000-06-08 | Sepracor Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
WO2002045658A2 (en) * | 2000-10-19 | 2002-06-13 | Teva Pharmaceutical Industries Ltd. | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
WO2002102129A2 (en) * | 2001-01-17 | 2002-12-27 | Diffucap Chemobras Quimica E Farmaceutica Ltda. | Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
GB8902209D0 (en) * | 1989-02-01 | 1989-03-22 | Wyeth John And Brother Limited | Preparation of cyclohexanol derivatives and novel thioamide intermediates |
DK0639374T3 (en) * | 1993-06-28 | 2002-05-06 | American Home Prod | New methods of treatment using phenethyl derivatives |
US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
US20020022662A1 (en) * | 1999-06-15 | 2002-02-21 | American Home Products Corporation | Enantiomers of O-desmethyl venlafaxine |
JP2003518485A (en) * | 1999-12-23 | 2003-06-10 | ファイザー・プロダクツ・インク | Pharmaceutical composition giving improved drug concentration |
US20020183553A1 (en) * | 2000-10-19 | 2002-12-05 | Ben-Zion Dolitzky | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
-
2003
- 2003-03-27 AR ARP030101073A patent/AR039165A1/en unknown
- 2003-03-27 US US10/397,381 patent/US20030191347A1/en not_active Abandoned
- 2003-03-27 WO PCT/EP2003/003320 patent/WO2003082806A1/en not_active Application Discontinuation
- 2003-03-27 AR ARP030101074A patent/AR039166A1/en unknown
- 2003-03-27 WO PCT/EP2003/003311 patent/WO2003082262A2/en not_active Application Discontinuation
- 2003-03-27 AU AU2003226748A patent/AU2003226748A1/en not_active Abandoned
- 2003-03-27 AU AU2003226752A patent/AU2003226752A1/en not_active Abandoned
- 2003-03-27 EP EP03745289A patent/EP1487429A2/en not_active Withdrawn
- 2003-03-27 US US10/397,353 patent/US20030190352A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999022724A2 (en) * | 1997-11-05 | 1999-05-14 | American Home Products Corporation | Extended release formulation containing venlafaxin |
WO2000032555A1 (en) * | 1998-12-01 | 2000-06-08 | Sepracor Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
WO2002045658A2 (en) * | 2000-10-19 | 2002-06-13 | Teva Pharmaceutical Industries Ltd. | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
WO2002102129A2 (en) * | 2001-01-17 | 2002-12-27 | Diffucap Chemobras Quimica E Farmaceutica Ltda. | Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product |
Also Published As
Publication number | Publication date |
---|---|
US20030190352A1 (en) | 2003-10-09 |
WO2003082806A1 (en) | 2003-10-09 |
AR039166A1 (en) | 2005-02-09 |
EP1487429A2 (en) | 2004-12-22 |
AR039165A1 (en) | 2005-02-09 |
AU2003226748A8 (en) | 2003-10-13 |
AU2003226748A1 (en) | 2003-10-13 |
US20030191347A1 (en) | 2003-10-09 |
AU2003226752A1 (en) | 2003-10-13 |
WO2003082262A2 (en) | 2003-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003082262A3 (en) | Compositions of venlafaxine base | |
WO2007146248A3 (en) | Stable laquinimod preparations | |
IL203923A (en) | Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds | |
HUP0401241A3 (en) | Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them | |
HUP0302230A3 (en) | Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them | |
HUP0401619A3 (en) | Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them | |
HUP0204110A3 (en) | Amphiphilic prodrugs, process for preparation and use of pharmaceutical compositions containing them | |
WO2006089674A3 (en) | Tablets with improved drug substance dispersibility | |
AU2001236207A1 (en) | Powder formulation | |
HUP0402063A3 (en) | Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof | |
AU2003244632A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
IL195294A (en) | Process for producing high purity safinamide or ralfinamide, use thereof in the preparation of medicaments and pharmaceutical formulations containing them | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
AU2003244649A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
DE602004011966D1 (en) | Heterocyclylverbindungen | |
HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
HUP0303813A3 (en) | Arylsulfonamides as antiviral agents, process for preparation of the compounds and pharmaceutical compositions containing them | |
WO2007075838A3 (en) | Pure and stable tiotropium bromide | |
HUP0301228A3 (en) | 3-azabicyclo(3.1.0)hexane derivatives having opioid receptor affinity, process for their preparation and pharmaceutical compositions containing them | |
HUP0204202A3 (en) | Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it | |
AU2003232941A1 (en) | N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them | |
AU2001256570A1 (en) | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them | |
IL172408A0 (en) | Use of bicyclo[2.2.1] heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
AU2002348829A1 (en) | Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003745289 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003745289 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003745289 Country of ref document: EP |